Skip to content

A Randomized Controlled Trial of Radical Resection for Colorectal Cancer Assisted by Mobile Laparoscopic Display Systems

A Randomized Controlled Trial of Radical Resection for Colorectal Cancer Assisted by Mobile Laparoscopic Display Systems

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094512
Enrollment
Unknown
Registered
2024-12-24
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Experimental group:The surgeon performed radical resection of colorectal cancer using a mobile laparoscopic system
Control group:The surgeon performed radical resection of colorectal cancer using a conventional laparoscopic system

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Adult male and female, aged between 18 and 75 years old (2) Colorectal adenocarcinoma was pathologically confirmed by colonoscopy biopsy (3) Preoperative imaging diagnosis was cT1-4aNxM0 or ycT1-T3Nx (4) The maximum diameter of the tumor diagnosed by preoperative imaging should not exceed 5cm (5) No local complications before surgery (no obstruction, incomplete obstruction, no massive active bleeding, no perforation, abscess formation, no local invasion) (6) The hematopoietic functions of the heart, lung, liver, kidney and bone marrow meet the requirements of surgery and anesthesia (7) Sign informed consent

Exclusion criteria

Exclusion criteria: (1) Previous or concurrent history of other malignant colorectal tumors (2) Simultaneous diagnosis of multiple primary colorectal tumors (3) There are contraindication of laparoscopic surgery, such as severe cardiopulmonary insufficiency (4) Patients who have undergone multiple abdominal and pelvic surgeries or extensive abdominal adhesion (5) Patients with intestinal obstruction, intestinal perforation, intestinal bleeding and other emergency operations (6) The primary tumor invasions the abdominal wall and/or adjacent organs, resulting in the inability to remove R0 (7) Patients with familial adenomatous polyposis, colorectal cancer associated with Lynch syndrome, and active stage of inflammatory bowel disease (8) ASA grade >=IV and/or ECOG physical status score >=2 points (9) Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery (10) Pregnant or lactating women (11) Have a history of serious mental illness (12) Patients with uncontrolled infection before operation

Design outcomes

Primary

MeasureTime frame
Incidence of complications within 30 days after surgery;

Secondary

MeasureTime frame
Operation time ;Intraoperative blood loss;Postoperative recovery exhaust time;Feeding time after operation;Postoperative hospital stay;Transfer operation situation;Postoperative pathological specimen evaluation;Intraoperative Subjective Fatigue Perception Scale (Borg CR10);

Countries

China

Contacts

Public ContactWang Guiyu

The Second Affiliated Hospital of Harbin Medical University

guiywang@163.com+86 139 4513 3256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026